Balls et al. (1995) Data Sorted By Substance

IRE BRD: Appendix C1
Substance
Acetone
Acetone
Acetone
Acetone
Ammonium nitrate
Ammonium nitrate
Ammonium nitrate
Ammonium nitrate
L-Aspartic acid
L-Aspartic acid
L-Aspartic acid
L-Aspartic acid
Benzalkonium chloride (10%)
Benzalkonium chloride (10%)
Benzalkonium chloride (10%)
Benzalkonium chloride (10%)
Benzalkonium chloride (5%)
Benzalkonium chloride (5%)
Benzalkonium chloride (5%)
Benzalkonium chloride (5%)
Benzalkonium chloride (1 %)
Benzalkonium chloride (1 %)
Benzalkonium chloride (1 %)
Benzalkonium chloride (1 %)
Butyl acetate
Butyl acetate
Butyl acetate
Butyl acetate
g-Butyrolactone
g-Butyrolactone
g-Butyrolactone
g-Butyrolactone
Captan 90 concentrate
Captan 90 concentrate
Captan 90 concentrate
Captan 90 concentrate
4-Carboxybenzaldehyde
Balls et al. (1995) Data Sorted By Substance
CASRN
Form Tested
Testing Lab
67-64-1
67-64-1
67-64-1
67-64-1
6484-52-2
6484-52-2
6484-52-2
6484-52-2
70-47-3
70-47-3
70-47-3
70-47-3
8001-54-5
8001-54-5
8001-54-5
8001-54-5
8001-54-5
8001-54-5
8001-54-5
8001-54-5
8001-54-5
8001-54-5
8001-54-5
8001-54-5
123-86-4
123-86-4
123-86-4
123-86-4
96-48-0
96-48-0
96-48-0
96-48-0
133-06-2
133-06-2
133-06-2
133-06-2
619-66-9
Liquid
Liquid
Liquid
Liquid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Solid
Solid
Solid
Solid
Solid
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
March 2006
Opacity
Swelling
1 Hr
4 Hr
1 Hr
4 Hr
3
3
3.7
2
0
0
0
0
0
0
0
1
2
2
1
1.7
2
2
0
1.3
1
2
0.7
0
0
0
0
0
1
0
0
0
2
0
0
1
0
2
2
0.2
0
0
0
0
0
0
0
0
1
3
3
2
2
2
2.7
1.3
1
0
0
0
0
0
0
0.7
0.7
3
2
1
0.7
2
1.7
0
0.3
0
10
32.6
5.5
13
10
3
9.1
7
5
0
9.2
6
20
41.7
24
60
29.2
21.5
27.6
51
20.8
18.8
24.8
31
0
9.4
5.8
11
19.3
27.4
20
19
0
12
8.9
5
5
25
76.3
11.3
15
25
3
12.7
0
5
0
15.3
4
80
62.9
37.4
112
66.4
115.6
114.9
100
20.8
61.7
47.8
81
5
29.1
7.8
17
29.1
49.6
30.6
44
10
31.6
13.4
20
5
C-5
In Vitro
Overall In
Irritancy
Vitro Irritancy
Classification Classification
Severe
Severe
Severe
Nonsevere
Nonsevere
Severe
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Nonsevere
Nonsevere
Severe
Nonsevere
Nonsevere
Severe
Severe
Severe
Severe
Severe
Nonsevere
Nonsevere
Severe
Nonsevere
Nonsevere
Nonsevere
Nonsevere
IRE BRD: Appendix C1
Balls et al. (1995) Data Sorted By Substance
Substance
CASRN
Form Tested
Testing Lab
4-Carboxybenzaldehyde
4-Carboxybenzaldehyde
4-Carboxybenzaldehyde
Cetylpyridinium bromide (10%)
Cetylpyridinium bromide (10%)
Cetylpyridinium bromide (10%)
Cetylpyridinium bromide (10%)
Cetylpyridinium bromide (6%)
Cetylpyridinium bromide (6%)
Cetylpyridinium bromide (6%)
Cetylpyridinium bromide (6%)
Cetylpyridinium bromide (0.1%)
Cetylpyridinium bromide (0.1%)
Cetylpyridinium bromide (0.1%)
Cetylpyridinium bromide (0.1%)
Chlorhexidine
Chlorhexidine
Chlorhexidine
Chlorhexidine
Cyclohexanol
Cyclohexanol
Cyclohexanol
Cyclohexanol
Dibenzoyl-L-tartaric acid
Dibenzoyl-L-tartaric acid
Dibenzoyl-L-tartaric acid
Dibenzoyl-L-tartaric acid
Dibenzyl phosphate
Dibenzyl phosphate
Dibenzyl phosphate
Dibenzyl phosphate
2,6-Dichlorobenzoyl chloride
2,6-Dichlorobenzoyl chloride
2,6-Dichlorobenzoyl chloride
2,6-Dichlorobenzoyl chloride
2,2-Dimethylbutanoic acid
2,2-Dimethylbutanoic acid
619-66-9
619-66-9
619-66-9
140-72-7
140-72-7
140-72-7
140-72-7
140-72-7
140-72-7
140-72-7
140-72-7
140-72-7
140-72-7
140-72-7
140-72-7
55-56-1
55-56-1
55-56-1
55-56-1
108-93-0
108-93-0
108-93-0
108-93-0
2743-38-6
2743-38-6
2743-38-6
2743-38-6
1623-08-1
1623-08-1
1623-08-1
1623-08-1
4659-45-4
4659-45-4
4659-45-4
4659-45-4
595-37-9
595-37-9
Solid
Solid
Solid
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solid
Solid
Solid
Solid
Liquid
Liquid
Liquid
Liquid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
March 2006
Opacity
Swelling
1 Hr
4 Hr
1 Hr
4 Hr
0
0
1
1
2
0
0.33
1
0
0.3
1
0
0
0
0
3
0
1
1
2
0
1
1.33
3
0
0
1
1
0
0
1
1
0
1
1
3
3
0
0.7
1
2
3
1
0.7
2
2.7
1.3
1
0
0
0
0
4
2
2.7
2
3
2
2
3
3
2.3
0.3
2
1
2
1
0.3
2.3
2
2.3
1
3
3
11.1
2.8
6
23.7
23
11.7
13
30
28.1
13.6
14
24.2
14.9
8.6
11
*
19.4
17
44
13.8
18.4
29
36
50
5.9
11.8
5
5.1
7.4
14.6
11
3.3
21.6
5.2
4
29.8
41.5
25.6
13.2
8
31.6
87.4
30.1
25
30
46.7
26.3
25
25
30.6
8.6
15
*
37.8
54.7
115
68.1
60.3
103
97
50
13.3
16.7
18
5.1
25.9
20.8
14
9.9
36.3
24.2
14
45.6
72.6
C-6
In Vitro
Overall In
Irritancy
Vitro Irritancy
Classification Classification
Severe
Nonsevere
Nonsevere
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Nonsevere
Nonsevere
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Severe
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Severe
Nonsevere
Nonsevere
Severe
Severe
Severe
IRE BRD: Appendix C1
Substance
2,2-Dimethylbutanoic acid
2,2-Dimethylbutanoic acid
2,5-Dimethylhexanediol
2,5-Dimethylhexanediol
2,5-Dimethylhexanediol
2,5-Dimethylhexanediol
Ethanol
Ethanol
Ethanol
Ethanol
Ethyl acetate
Ethyl acetate
Ethyl acetate
Ethyl acetate
2-Ethyl-1-hexanol
2-Ethyl-1-hexanol
2-Ethyl-1-hexanol
2-Ethyl-1-hexanol
Ethyl-2-methylacetoacetate
Ethyl-2-methylacetoacetate
Ethyl-2-methylacetoacetate
Ethyl-2-methylacetoacetate
Ethyl trimethyl acetate
Ethyl trimethyl acetate
Ethyl trimethyl acetate
Ethyl trimethyl acetate
Fomesafen
Fomesafen
Fomesafen
Fomesafen
Glycerol
Glycerol
Glycerol
Glycerol
n-Hexanol
n-Hexanol
n-Hexanol
Balls et al. (1995) Data Sorted By Substance
CASRN
Form Tested
Testing Lab
595-37-9
595-37-9
110-03-2
110-03-2
110-03-2
110-03-2
64-17-5
64-17-5
64-17-5
64-17-5
141-78-6
141-78-6
141-78-6
141-78-6
104-76-7
104-76-7
104-76-7
104-76-7
609-14-3
609-14-3
609-14-3
609-14-3
3938-95-2
3938-95-2
3938-95-2
3938-95-2
72128-02-0
72128-02-0
72128-02-0
72128-02-0
56-81-5
56-81-5
56-81-5
56-81-5
111-27-3
111-27-3
111-27-3
Liquid
Liquid
Solid
Solid
Solid
Solid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Solid
Solid
Solid
Solid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
March 2006
Opacity
Swelling
1 Hr
4 Hr
1 Hr
4 Hr
3
2
1
0
0
0.33
2
1
1.2
2.67
0
0
0
0
1
0
0
0
0
1
0
0.67
0
0
0
0
3
0
0
0.33
0
0
0
0
1.3
0
0
2.3
2.7
1
0
0
0.7
3
3
2.3
2
2
2
0.7
1
1
1
1.7
2
1
2.7
2
1
1
2
0.3
0
3
1.7
0
0
1
0
0.3
0
2
3
2.7
34
29
35
10.3
5.9
10
50
14.2
17.8
25
6.5
18
19.8
14
16.7
5.9
8.3
12
2.5
25.2
25.5
12
5.3
14.3
2.9
4
25
2.3
5.5
4
9.2
5.2
11.3
5
20.5
13.7
19.1
76
78
35
14
11.8
5
60.8
48.5
41
60
13.7
45.1
38.7
25
16.7
20.7
24.7
19
5
29.4
36.5
14
10.5
19.3
13.3
5
25
29.3
12
-1
10
5.2
11.3
4
38.5
43.6
62.1
C-7
In Vitro
Overall In
Irritancy
Vitro Irritancy
Classification Classification
Severe
Severe
Severe
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Severe
Severe
Severe
Severe
Severe
Nonsevere
Severe
Severe
Severe
Severe
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Severe
Severe
Severe
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Severe
Severe
Severe
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Severe
Severe
Severe
Severe
IRE BRD: Appendix C1
Substance
n-Hexanol
Imidazole
Imidazole
Imidazole
Imidazole
iso-Butanol
iso-Butanol
iso-Butanol
iso-Butanol
iso-Propanol
iso-Propanol
iso-Propanol
iso-Propanol
Maneb
Maneb
Maneb
Maneb
Methyl acetate
Methyl acetate
Methyl acetate
Methyl acetate
Methyl cyanoacetate
Methyl cyanoacetate
Methyl cyanoacetate
Methyl cyanoacetate
Methylcyclopentane
Methylcyclopentane
Methylcyclopentane
Methylcyclopentane
Methyl ethyl ketone
Methyl ethyl ketone
Methyl ethyl ketone
Methyl ethyl ketone
Methyl isobutyl ketone
Methyl isobutyl ketone
Methyl isobutyl ketone
Methyl isobutyl ketone
Balls et al. (1995) Data Sorted By Substance
CASRN
Form Tested
Testing Lab
111-27-3
288-32-4
288-32-4
288-32-4
288-32-4
78-83-1
78-83-1
78-83-1
78-83-1
67-63-0
67-63-0
67-63-0
67-63-0
12427-38-2
12427-38-2
12427-38-2
12427-38-2
79-20-9
79-20-9
79-20-9
79-20-9
105-34-0
105-34-0
105-34-0
105-34-0
96-37-7
96-37-7
96-37-7
96-37-7
78-93-3
78-93-3
78-93-3
78-93-3
108-10-1
108-10-1
108-10-1
108-10-1
Liquid
Solid
Solid
Solid
Solid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Solid
Solid
Solid
Solid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
March 2006
Opacity
Swelling
1 Hr
4 Hr
1 Hr
4 Hr
1.33
2
3
3
2
2
0
2
1.33
1.7
2
0
1.67
3
0
1
0
1
0
1
0
0
0
0
0.33
0
0
0
0
2
1
0
0.67
1
0
0
0
3
3
3
3
2
3
2
3
2
3
2.3
0.7
1.7
2
2
0
0
3
0
1.7
1.7
0
2
0.3
0.3
0
0
0
0
3
2
2.3
2.3
2
3
1.3
0
21
50
45.5
45.8
38
20
14.5
26
40
4
30.9
13.1
16
49.2
29.9
10.8
6
21
12
12.2
15
5.1
5.8
2.9
6
7.4
17.6
2.8
5
20.8
20.7
29.4
14
34.5
29.3
0
9
49
80
75.8
63.2
80
85
47
78.9
91
22.4
65.5
23.4
32
52.5
37.3
16.5
0
49.6
18.8
28.1
26
5.1
8.7
6.8
7
7.4
21
5.6
4
91.7
56.3
51
46
40.4
64.6
8.7
23
C-8
In Vitro
Overall In
Irritancy
Vitro Irritancy
Classification Classification
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Nonsevere
Severe
Severe
Severe
Severe
Nonsevere
Nonsevere
Severe
Severe
Nonsevere
Severe
Severe
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Nonsevere
Nonsevere
IRE BRD: Appendix C1
Balls et al. (1995) Data Sorted By Substance
Substance
CASRN
Form Tested
Testing Lab
1-Naphthalene acetic acid
1-Naphthalene acetic acid
1-Naphthalene acetic acid
1-Naphthalene acetic acid
1-Naphthalene acetic acid, Na salt
1-Naphthalene acetic acid, Na salt
1-Naphthalene acetic acid, Na salt
1-Naphthalene acetic acid, Na salt
n-Octanol
n-Octanol
n-Octanol
n-Octanol
p-Fluoraniline
p-Fluoraniline
p-Fluoraniline
p-Fluoraniline
Polyethylene glycol 400
Polyethylene glycol 400
Polyethylene glycol 400
Polyethylene glycol 400
Potassium cyanate
Potassium cyanate
Potassium cyanate
Potassium cyanate
Promethazine HCl
Promethazine HCl
Promethazine HCl
Promethazine HCl
Pyridine
Pyridine
Pyridine
Pyridine
Quinacrine
Quinacrine
Quinacrine
Quinacrine
Sodium hydroxide (10%)
86-87-3
86-87-3
86-87-3
86-87-3
61-31-4
61-31-4
61-31-4
61-31-4
111-87-5
111-87-5
111-87-5
111-87-5
371-40-4
371-40-4
371-40-4
371-40-4
25322-68-3
25322-68-3
25322-68-3
25322-68-3
590-28-3
590-28-3
590-28-3
590-28-3
58-33-3
58-33-3
58-33-3
58-33-3
110-86-1
110-86-1
110-86-1
110-86-1
69-05-6
69-05-6
69-05-6
69-05-6
1310-73-2
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Liquid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Liquid
Liquid
Liquid
Liquid
Solid
Solid
Solid
Solid
Solution
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
March 2006
Opacity
Swelling
1 Hr
4 Hr
1 Hr
4 Hr
0
0
0
1
2
0
0
2
0
0
0
0
2
0
1.3
1.67
1
0
0
0
0
0
0
0
2
1
1
2
1
2
2
2.33
0
0
0
0
3
0.3
2.3
0
1
3
2.7
3
2
1
2
1.8
1
2
2
3
2.2
1
1
0
0
0
0
0
0
2
3
2.3
2
3
3
3
2.3
0
0
0.7
0
4
15
21.9
1
10
67
16.1
61
84
4.4
17.6
14.2
11
25
27.4
33.7
25
29.4
20.7
6
4
9.1
1.5
5.3
5
17.5
76.1
20.8
62
18.2
10.3
34.9
40
10.5
0
13
5
86
15
24.1
2.8
13
108.7
41.6
125.1
155
14.8
26.1
29.9
16
55
63.7
68.7
70
31.1
27.4
12.8
-1
9.1
1.5
11.5
-1
45
117.1
86.9
110
53.7
48.5
42.4
75
10.5
0.7
16.7
4
110.5
C-9
In Vitro
Overall In
Irritancy
Vitro Irritancy
Classification Classification
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Severe
Severe
Severe
Severe
Severe
Nonsevere
Severe
Severe
Severe
Nonsevere
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Severe
Severe
IRE BRD: Appendix C1
Substance
Sodium hydroxide (10%)
Sodium hydroxide (10%)
Sodium hydroxide (10%)
Sodium hydroxide (1%)
Sodium hydroxide (1%)
Sodium hydroxide (1%)
Sodium hydroxide (1%)
Sodium lauryl sulfate (15 %)
Sodium lauryl sulfate (15 %)
Sodium lauryl sulfate (15 %)
Sodium lauryl sulfate (15 %)
Sodium lauryl sulfate (3 %)
Sodium lauryl sulfate (3 %)
Sodium lauryl sulfate (3 %)
Sodium lauryl sulfate (3 %)
Sodium oxalate
Sodium oxalate
Sodium oxalate
Sodium oxalate
Sodium perborate tetrahydrate
Sodium perborate tetrahydrate
Sodium perborate tetrahydrate
Sodium perborate tetrahydrate
tetra-Aminopyrimidine sulfate
tetra-Aminopyrimidine sulfate
tetra-Aminopyrimidine sulfate
tetra-Aminopyrimidine sulfate
Thiourea
Thiourea
Thiourea
Thiourea
Toluene
Toluene
Toluene
Toluene
Trichloroacetic acid (30%)
Trichloroacetic acid (30%)
Balls et al. (1995) Data Sorted By Substance
CASRN
Form Tested
Testing Lab
1310-73-2
1310-73-2
1310-73-2
1310-73-2
1310-73-2
1310-73-2
1310-73-2
151-21-3
151-21-3
151-21-3
151-21-3
151-21-3
151-21-3
151-21-3
151-21-3
62-76-0
62-76-0
62-76-0
62-76-0
10486-00-7
10486-00-7
10486-00-7
10486-00-7
5392-28-9
5392-28-9
5392-28-9
5392-28-9
62-56-6
62-56-6
62-56-6
62-56-6
108-88-3
108-88-3
108-88-3
108-88-3
76-03-9
76-03-9
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Solid
Liquid
Liquid
Liquid
Liquid
Solution
Solution
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
March 2006
Opacity
Swelling
1 Hr
4 Hr
1 Hr
4 Hr
3
3.7
2
1.3
0
1
1.67
0
0
0
0.33
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
1
0
0
0
0
1
0
0.7
1
4
3
4
4
4
2
3
3
3
1
2
0.3
2
1
0
0
1
0
0
0
0
0
0
0
0
1
0
0
2
0
0
0
0.7
1
0
1
0
4
4
107.8
*
111
40
41.7
57.1
62
21.1
13.5
14.5
16
5.3
13.4
8.4
12
5
0.8
17.3
6
5
0.8
2.9
4
12.5
0.7
1
3
10
5.1
5.7
7
28.3
11.1
10.1
8
*
44
144.3
*
160
85
65.2
121.9
102
21.1
26.3
22.3
24
15.8
22.4
9.3
14
5
6.7
22
5
5
2.3
14.7
0
25
4.4
2.9
9
10
5.1
5.7
4
30
37.6
17.5
6
*
100.8
C-10
In Vitro
Overall In
Irritancy
Vitro Irritancy
Classification Classification
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Nonsevere
Nonsevere
Severe
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Severe
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Nonsevere
Severe
Severe
Severe
Nonsevere
Nonsevere
Severe
Severe
Severe
IRE BRD: Appendix C1
Substance
Trichloroacetic acid (30%)
Trichloroacetic acid (30%)
Trichloroacetic acid (3%)
Trichloroacetic acid (3%)
Trichloroacetic acid (3%)
Trichloroacetic acid (3%)
Triton X-100 (10 %)
Triton X-100 (10 %)
Triton X-100 (10 %)
Triton X-100 (10 %)
Triton X-100 (5 %)
Triton X-100 (5 %)
Triton X-100 (5 %)
Triton X-100 (5 %)
Tween 20
Tween 20
Tween 20
Tween 20
Balls et al. (1995) Data Sorted By Substance
CASRN
Form Tested
Testing Lab
76-03-9
76-03-9
76-03-9
76-03-9
76-03-9
76-03-9
9002-93-1
9002-93-1
9002-93-1
9002-93-1
9002-93-1
9002-93-1
9002-93-1
9002-93-1
9005-64-5
9005-64-5
9005-64-5
9005-64-5
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Solution
Liquid
Liquid
Liquid
Liquid
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
IREA 26
IREA 23
IREA 28
IREA 29
March 2006
Opacity
Swelling
1 Hr
4 Hr
1 Hr
4 Hr
3.7
3
0
1
0.7
1
2
0
0
0.67
2
0
0
0.33
0
0
0
0
3.7
3
1
2
0
0
3
2
2
2.3
3
2
1.3
1.5
0
1
0
0
*
4
6
12.1
7.2
7
8.8
24.2
36.2
39
25.4
23.3
10
20
12.6
28.1
6.4
7
*
54
6
36.2
20.6
11
19.2
32.6
95.3
80
31.6
30.1
25.2
45
15.1
29.6
14.7
4
C-11
In Vitro
Overall In
Irritancy
Vitro Irritancy
Classification Classification
Severe
Severe
Nonsevere
Nonsevere
Severe
Nonsevere
Nonsevere
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Severe
Nonsevere
Nonsevere
Severe
Nonsevere
Nonsevere